2026-05-18
MegaPro Biomedical Achieves Preliminary Alignment with U.S. FDA on Phase III Clinical Development Plan for MPB-1523
MegaPro Biomedical held a Type C meeting with the U.S. Food and Drug Administration (FDA) on April 14, 2026, to discuss the manufacturing specifications and Phase III clinical trial design...
Read more2026-04-17
MegaPro Biomedical's Cell Therapy Product MPB‑2354 Selected as Top 8 Finalist in the Healthcare Sector at SelectUSA Tech
MegaPro Biomedical Co., Ltd. (“MegaPro Biomedical”, TPEx: 6827) today announced that its proprietary, nanotechnology‑enabled cell therapy product MPB‑2354 has been selected as a Top 8 finalist in the Healthcare sector...
Read more2026-03-16
MegaPro Biomedical Announces On‑Track Progress of Global Phase III Clinical Trial Program for MPB‑1523
MegaPro Biomedical Announces On‑Track Progress of Global Phase III Clinical Trial Program for MPB‑1523 Taipei, Taiwan – December 17, 2025 MegaPro Biomedical Co., Ltd. (“MegaPro”, TPEx: 6827), a Taiwan‑based clinical‑stage pharmaceutical company...
Read more2026-03-16
MegaPro Biomedical Announces Acceptance of Clinical Study Report for MPB‑1734 Phase 1/2a Trial by Taiwan FDA
MegaPro Biomedical Announces Acceptance of Clinical Study Report for MPB‑1734 Phase 1/2a Trial by Taiwan FDA Taipei, Taiwan – December 29, 2025 MegaPro Biomedical Co., Ltd. (“MegaPro”, TPEx: 6827), a Taiwan‑based clinical‑stage...
Read more
MPB-1734: A New Formulation Anti-cancer Drug
The MPB-1734 is an anticancer drug of a new pharmaceutical formulation. After coating commercially available paclitaxel anticancer drugs based on the company’s nanocell technology platform, animal experiments have found that...
Read more
MPB-1514 Iron Injection for the Treatment of Iron Deficiency Anemia
◆ What is iron deficiency anemia? The main causes of iron deficiency anemia (IDA) can be summarized into 4 categories: (1) insufficient iron intake, (2) dysfunctions in iron...
Read more
MPB-1523 MRI Contrast Medium - Hepatocellular carcinoma
◆ Current Causes and Diagnosis of Hepatocellular Carcinoma In general, liver cancer, like other liver diseases, is not prone to symptoms in the early stage. Once obvious subjective...
Read more
Clinical Trial Platform for New Drugs
New Drug Clinical Trial Platform Continuing the achievements of the various technology platforms of the R & D center, promoting and integrating clinical trials of new drugs, and mastering the technology...
Read more
Immune Cell Calibration Technology Platform
Image Calibration of Immune Cells With the rapid development of cell biology and molecular biology technology, the research on the technology of using magnetic nanoparticles for cell identification continues to increase...
Read more
Cellular and Molecular Imaging Technology Platform
The application of MRI Imaging Technology (Magnetic Resonance Imaging, MRI) is becoming more and more popular in diagnostic imaging medicine, and it has been growing rapidly in recent years. MRI images...
Read more
Nano Graft Technology Platform
Nano grafting technology Nano-graft reaction is to combine nano-particles and modifiers through chemical reaction to change the surface structure and state of nano-particles to achieve the purpose of surface denaturation. Nano-grafting...
Read more
Nanomedicine technology
Nanomedicine Technology Nanotechnology is a practical application of technology that uses physical cutting, chemical synthesis, and other methods to achieve the control of the structure and shape of objects to attain...
Read moreNano Encapsulation Technology Platform
Nano Encapsulation Technology Nano encapsulation technology mainly improves the clinical unmet needs and limitations of clinical use of drugs through the unique properties of nano carriers and drug encapsulation technology, such...
Read more